Hepatocellular Carcinoma (HCC) is the most common cause of primary liver cancer. Curative treatments include surgery and transplant, but many patients don't know they have the disease until it's too late. In this week's article, we explore what HCC is, risks and complications of the disease, and what people can do to find out if they have signs of the HCC before it spreads too far.

References:

Koren, M.J. & Kapila, N. (Hosts). (2025). The liver: Common causes of complications, cirrhosis, and cancer. [Podcast Episode]. In MedEvidence! Truth Behind the Data. MedEvidence. https://www.buzzsprout.com/1926091/episodes/17268919

El-Serag, H. B., & Davila, J. A. (2011). Surveillance for HepatoCellular Carcinoma: in whom and how?. Therapeutic advances in gastroenterology, 4(1), 5-10. https://journals.sagepub.com/doi/pdf/10.1177/1756283X10385964

Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025). Cancer statistics, 2025. Ca, 75(1), 10. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21871

Benson, A. B., D’Angelica, M. I., Abbott, D. E., Anaya, D. A., Anders, R., Are, C., ... & Darlow, S. D. (2021). Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(5), 541-565. https://jnccn.org/view/journals/jnccn/19/5/article-p541.xml

Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., ... & Marrero, J. A. (2018). AASLD guidelines for the treatment of HepatoCellular Carcinoma. Hepatology, 67(1), 358-380.https://pubmed.ncbi.nlm.nih.gov/28130846/

Singal, A. G., Mittal, S., Yerokun, O. A., Ahn, C., Marrero, J. A., Yopp, A. C., ... & Scaglione, S. J. (2017). HepatoCellular Carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. The American journal of medicine, 130(9), 1099-1106. https://www.amjmed.com/article/S0002-9343(17)30128-6/fulltext

Llovet, J. M., Pinyol, R., Kelley, R. K., El-Khoueiry, A., Reeves, H. L., Wang, X. W., ... & Villanueva, A. (2022). Molecular pathogenesis and systemic therapies for HepatoCellular Carcinoma. Nature cancer, 3(4), 386-401. https://www.nature.com/articles/s43018-022-00357-2

Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70.https://www.cell.com/cell/fulltext/S0092-8674(00)81683-9

Nathani, P., Gopal, P., Rich, N., Yopp, A., Yokoo, T., John, B., ... & Singal, A. G. (2021). HepatoCellular Carcinoma tumour volume doubling time: a systematic review and meta-analysis. Gut, 70(2), 401-407. https://gut.bmj.com/content/70/2/401.abstract